Insider · CIK 0001551951
Stephen J Galli
Files at ATOS (ATOSSA THERAPEUTICS, INC.). First filing -, latest -.
Stephen J Galli files SEC Form 4 as director at ATOS (ATOSSA THERAPEUTICS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Stephen J Galli has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 12, 2026 | ATOS ATOSSA THERAPEUTICS, INC. | AGrant or award Common Stock | +10,000 | $0.00 | $0 | 10,006 | May 14, 2026 |
| May 15, 2025 | ATOS ATOSSA THERAPEUTICS, INC. | AGrant or award Stock Option (right to buy)derivative | +125,000 | $0.00 | $0 | 125,000 | May 16, 2025 |
Questions about Stephen J Galli
Answered from the filings on this page, as of the latest one.
Is Stephen J Galli buying or selling?
Stephen J Galli has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Stephen J Galli's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Stephen J Galli has 0.
Where does Stephen J Galli file Form 4?
Stephen J Galli has filed Form 4 at ATOS (ATOSSA THERAPEUTICS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.